GlycoMimetics CEO chosen as new BIO chairwoman

04/24/2013 | American City Business Journals

GlycoMimetics President and CEO Rachel King has been elected as the 2013-2014 chairwoman of BIO, succeeding former Human Genome Sciences CEO Tom Watkins. King has been a part of national policy discussions with BIO and was among the group's representatives at a 2011 meeting on the approval process with FDA Commissioner Dr. Margaret Hamburg.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations